Neuroone Medical Technologies (NMTC) Amortizatization of Intangibles (2015 - 2023)
Neuroone Medical Technologies (NMTC) posted Amortizatization of Intangibles of $4568.0 for Q2 2023, down 77.43% on a QoQ basis from $20238.0 in Q1 2023.
Neuroone Medical Technologies (NMTC) Amortizatization of Intangibles (2015 - 2023) Analysis & Trends
Neuroone Medical Technologies' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $4568.0 for Q2 2023.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $4568.0 in Q2 2023, while the trailing twelve-month figure through Sep 2023 was $45571.0 (changed N/A YoY) and the FY2023 annual result came in at $45571.0, up 297.27% from the prior year.
- Amortizatization of Intangibles was $4568.0 for Q2 2023 at Neuroone Medical Technologies, down from $20238.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $20765.0 in Q4 2022 and bottomed at $4568.0 in Q2 2023.
- A 4-year average of $11012.5 and a median of $10420.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2019 — Amortizatization of Intangibles tumbled 62.51% — and 2020, when it surged 108.38%.
- Neuroone Medical Technologies' Amortizatization of Intangibles stood at $9898.0 in 2019, then gained by 11.81% to $11067.0 in 2020, then soared by 87.63% to $20765.0 in 2022, then sank by 78.0% to $4568.0 in 2023.
- Business Quant data shows NMTC's Amortizatization of Intangibles at $4568.0 in Q2 2023, $20238.0 in Q1 2023, and $20765.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Neuroone Medical Technologies | 14.85 Mn | 12.05 Mn | 990,264.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4,568.00 |
| Jun 30, 2023 | 4,568.00 |
| Mar 31, 2023 | 20,238.00 |
| Mar 31, 2023 | 20,238.00 |
| Dec 31, 2022 | 20,765.00 |
| Dec 31, 2022 | 20,765.00 |
| Mar 31, 2020 | 11,067.00 |
| Mar 31, 2020 | 11,067.00 |
| Dec 31, 2019 | 9,898.00 |
| Dec 31, 2019 | 9,898.00 |
| Sep 30, 2019 | 10,942.00 |
| Sep 30, 2019 | 10,942.00 |
| Jun 30, 2019 | 5,311.00 |
| Jun 30, 2019 | 5,311.00 |
| Mar 31, 2019 | 5,311.00 |
| Mar 31, 2019 | 5,311.00 |
| Jun 30, 2018 | 14,168.00 |
| Jun 30, 2018 | 14,168.00 |
| Mar 31, 2018 | 9,217.00 |
| Mar 31, 2018 | 9,217.00 |